MarketsStocksCONCORDBIO
CO

Concord Biotech Ltd

NSE: CONCORDBIOBSE: 543960Healthcare
1,236.00
+2.87%
NSE · 15-min delayed
Prev Close
₹1,876.00
Day High
₹1,244.90
Day Low
₹1,190.40
Mkt Cap
₹10,997 Cr
P / E
42.4
P / B
5.5
ROE
13.5%
52W High
₹2,150.40
52W Low
₹987.00
Key Metrics
Market Cap
₹10,997 Cr
P / E
42.42
P / B
5.45
EV / EBITDA
25.04
ROCE
27.4%
ROE
13.5%
Debt / Equity
0.00
Book Value
₹226.79
EPS
₹24.78
Div Yield
0.9%
Face Value
₹1
Revenue · ₹ Cr
1.0k
FY24
1.2k
FY25
1.1k
FY26
Net Profit · ₹ Cr
308
FY24
372
FY25
259
FY26
EPS · ₹ per share
₹29.4
FY24
₹35.5
FY25
₹24.8
FY26
P / E Ratio · price ÷ TTM EPS
30507191132638Apr 24Dec 24Sept 25Jun 26
P/E 50.0×Median 51.1×TTM EPS
Q1 2026 snapshot
Sales
₹341 Cr
Operating profit
-
OPM
-
Net profit
₹88 Cr
EPS
₹8.46
Scorecard · 7 axes
Quality
Strong
82/100
Valuation
Weak
42.4×
Growth
Good
+15.1%
Profitability
Strong
20.5%
Performance
Bad
-34.7%
Entry Point
Strong
57%
Red Flags
Strong
0 flags
Shareholding Pattern
44.1%Promoter
Promoter44.1%
FII7.8%
DII9.2%
Public38.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue244.22439.27217.67260.41287.74341.43
Net Profit75.921140.38744.05863.06363.64288.467
NPM %31.1%32.0%20.2%24.2%22.1%25.9%
AlertPre-trade